Evidence map›Paper›PMID 35276993›Full record

Trial reportNutrients2022

An Infant Formula with Large, Milk Phospholipid-Coated Lipid Droplets Supports Adequate Growth and Is Well-Tolerated in Healthy, Term Asian Infants: A Randomized, Controlled Double-Blind Clinical Trial.

Oon Hoe Teoh, Tan Pih Lin, Marieke Abrahamse-Berkeveld, Antoinette Winokan, Yap Seng Chong, Fabian Yap, Maya Marintcheva-Petrova, Eline M van der Beek, Lynette P Shek

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Journal of agricultural and food chemistry · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Oon Hoe TeohDepartment of Paediatrics, KK Women's and Children's Hospital, Singapore 229899, Singapore.ORCID 0000-0002-5100-1543
Tan Pih LinDepartment of Paediatrics, KK Women's and Children's Hospital, Singapore 229899, Singapore.ORCID 0000-0002-0742-7213
Marieke Abrahamse-BerkeveldDanone Nutricia Research, 3584 CT Utrecht, The Netherlands.ORCID 0000-0002-1899-2824
Antoinette WinokanNutricia Research, Singapore 138671, Singapore.
Yap Seng ChongSingapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore 119228, Singapore.
Fabian YapDepartment of Paediatrics, KK Women's and Children's Hospital, Singapore 229899, Singapore.ORCID 0000-0003-1083-7958
Maya Marintcheva-PetrovaDanone Nutricia Research, 3584 CT Utrecht, The Netherlands.
Eline M van der BeekDepartment of Paediatrics, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
Lynette P ShekSingapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore 119228, Singapore.
KK Women's and Children's Hospital · SGAgency for Science, Technology and Research · SGDanone (Netherlands) · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipids are essential for healthy infant growth and development. The structural complexity of lipids in human milk is not present in infant milk formula (IF). A concept IF was developed mimicking more closely the structure and composition of human milk fat globules. The current study evaluates whether a concept IF with large, milk phospholipid-coated lipid droplets (mode diameter 3 to 5 μm) is equivalent to standard IF with regard to growth adequacy and safety in healthy, term Asian infants. In this randomized, double-blind, controlled trial, infants were randomized after parents decided to introduce formula. Infants received a standard IF with (Control) or without the specific prebiotic mixture scGOS/lcFOS (9:1 ratio; Control w/o prebiotics), or a Concept IF with large, milk phospholipid-coated lipid droplets and the prebiotic mixture. A group of 67 breastfed infants served as a reference. As a priori defined, only those infants who were fully intervention formula-fed ≤28 days of age were included in the equivalence analysis (Control n = 29; Control w/o prebiotics n = 28; Concept n = 35, per-protocol population). Primary outcome was daily weight gain during the first four months of life, with the difference between the Concept and Control as the key comparison of interest. Additionally, adverse events, growth and tolerance parameters were evaluated. Equivalence of daily weight gain was demonstrated between the Concept and Control group after additional correction for ethnicity and birthweight (difference in estimated means of 0.1 g/d, 90%CI [-2.30, 2.47]; equivalence margin +/- 3 g/d). No clinically relevant group differences were observed in secondary growth outcomes, tolerance outcomes or number, severity or relatedness of adverse events. This study corroborates that an infant formula with large, milk phospholipid-coated lipid droplets supports adequate growth and is well tolerated and safe for use in healthy infants.

Indexed as

Infant FormulaPhospholipidsFemaleHumansInfantLipid DropletsMilk, HumanPrebioticsPhospholipidsPrebioticsgrowth adequacyinfant formulalipid droplet structuresafety

Identifiers

PMID35276993
PMCPMC8838783
OpenAlexW4210526099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.